Herantis Pharma to Participate in the Nordic Life Science Days, Sweden
Herantis Pharma Plc, Press Release, 7 August 2022 at 09:00 EEST Herantis Pharma Plc (“Herantis”), developing disease modifying therapies for Parkinson’s disease, today announced that CEO Antti Vuolanto and CFO Tone Kvåle will be presenting and holding 1x1 meetings at the Nordic Life Science Days (NLS) in Malmö, Sweden on September 28-29, 2022. Nordic Life Science Days is the largest Nordic partnering conference dedicated to the life science industry. Presentation Time: September 28, 11:12 a.m. EEST / 10:12 a.m. CEST The presentations will be accessible to event